<DOC>
	<DOCNO>NCT00496834</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy , arterial stiffness measure Pulse Wave Velocity ( PWV ) Losartan potassium group compare Carvedilol group 24 week treatment patient essential hypertension .</brief_summary>
	<brief_title>LAAS ( Losartan Anti-Atherosclerosis Study ) ( 0954-330 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Male Female adult , 18 year Essential Hypertension mean SBP ( systolic blood pressure ) ≥ 140 mm Hg mean DBP ( diastolic blood pressure ) ≥ 90 mm Hg* blood pressure measure Visit 1 ( week 2 ) Visit 2 ( week 0 ) . If diabetes patient , mean SBP ≥ 130 mm Hg mean DBP ≥ 80 mm Hg ( Mean blood pressure value measure consecutively least 2 minute apart ) Patient willing , able sign inform consent form Patient Is Pregnant Or Breastfeeding , Or Expecting To Conceive Within The Projected Duration Of The Study Patient Has Known Or Suspected Secondary Hypertension Of Any Etiology Patient history malignant hypertension Patient history cerebrovascular accident ( cerebral infarction ) myocardiac infarction within last 6 month Patient take antihypertensive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>